SHARON PHILLIPS: Open Payments
NPI 1356317739 · SAINT HELENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 30 payments from 11 companies in 2025. Trend: 2023 $354 · 2024 $504 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 5 | $141 |
| GlaxoSmithKline, LLC. | 4 | $107 |
| Actelion Pharmaceuticals US, Inc. | 4 | $97 |
| Lilly USA, LLC | 3 | $75 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $65 |
| Astellas Pharma US Inc | 2 | $59 |
| Verona Pharma, Inc. | 2 | $44 |
| Organon LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: Tyvaso, MOUNJARO, UPTRAVI, TRELEGY ELLIPTA, Veozah, Ohtuvayre, SHINGRIX, NEXPLANON.
Industry payments across CA — which companies pay providers there.
